Literature DB >> 29485015

Protein Tyrosine Phosphatase as Potential Therapeutic Target in various Disorders.

Shivani Verma1, Saurabh Sharma2.   

Abstract

BACKGROUND: Tyrosine-protein phosphatase is an enzyme that functions in a unit with tyrosine kinases to regulate signaling pathways. Several members of the PTP family link to human disease predisposition such as PTP1B, SH2, DEP1, and inhibition of these enzymes may represent an effective palliative therapy.
OBJECTIVE: This review aims to summarize the rapidly developing role of the PTPs in various physiological and pathological states.
RESULTS: Pharmacological inhibition of protein tyrosine phosphatase has been found to reduce endothelial dysfunction in different cardiovascular diseases related to metabolic disorders and it can be helpful for the management of other brain disorders associated with perhaps even in normal, agerelated cognitive decline. Tyrosine-protein phosphates have both stimulatory and inhibitory consequences on cancer-associated signaling pathways and deregulation of PTKs involves tumorgenesis.
CONCLUSION: Inhibition of protein tyrosine phosphatase plays an important function in the improvement of various diseases such as metabolic, cardiovascular disorders, cancer and autoimmune disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Protein tyrosine phosphatase; cardiovascular diseases; metabolic disorders; neurodegenerative disease; pathological states; therapeutic target.

Mesh:

Substances:

Year:  2018        PMID: 29485015     DOI: 10.2174/1874467211666180226161846

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  5 in total

1.  JNK1 and JNK3: divergent functions in hippocampal metabolic-cognitive function.

Authors:  Oriol Busquets; Triana Espinosa-Jiménez; Miren Ettcheto; Jordi Olloquequi; Mònica Bulló; Eva Carro; José Luis Cantero; Gemma Casadesús; Jaume Folch; Ester Verdaguer; Carme Auladell; Antoni Camins
Journal:  Mol Med       Date:  2022-05-04       Impact factor: 6.376

Review 2.  Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies.

Authors:  Lena Claesson-Welsh; Elisabetta Dejana; Donald M McDonald
Journal:  Trends Mol Med       Date:  2020-12-10       Impact factor: 11.951

3.  To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis.

Authors:  Ka Wu; Pingyuan Wei; Meizhen Liu; Xiaoliu Liang; Min Su
Journal:  J Adv Res       Date:  2019-05-15       Impact factor: 10.479

4.  Modulation of Proteome Profile in AβPP/PS1 Mice Hippocampus, Medial Prefrontal Cortex, and Striatum by Palm Oil Derived Tocotrienol-Rich Fraction.

Authors:  Hamizah Shahirah Hamezah; Lina Wati Durani; Daijiro Yanagisawa; Nor Faeizah Ibrahim; Wan Mohd Aizat; Suzana Makpol; Wan Zurinah Wan Ngah; Hanafi Ahmad Damanhuri; Ikuo Tooyama
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 5.  Recent advances in PTP1B signaling in metabolism and cancer.

Authors:  Olga Villamar-Cruz; Marco A Loza-Mejía; Luis E Arias-Romero; Ignacio Camacho-Arroyo
Journal:  Biosci Rep       Date:  2021-11-26       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.